NCT03084016 (ABBA) is a clinical trial in Asthma Acute, sponsored by University of East Anglia.

Who is sponsoring NCT03084016?

NCT03084016 is sponsored by University of East Anglia.

What condition does NCT03084016 study?

NCT03084016 studies Asthma Acute.

Is NCT03084016 still recruiting?

NCT03084016 is currently completed. Last updated 20 October 2022.

Last reviewed 2022-10-20 · How we verify

NCT03084016: ABBA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Asthma Breath Biomarker Assessment

Completed Last updated 20 October 2022

What this trial tests

trial in Asthma Acute in 84 participants. Completed in 31 December 2018.

Timeline

6 March 2017

Primary endpoint
31 December 2018

31 December 2018

Quick facts

Lead sponsor	University of East Anglia
Status	Completed
Study type	OBSERVATIONAL
Enrollment	84
Start date	6 March 2017
Primary completion	31 December 2018
Estimated completion	31 December 2018
Sites	1 location across United Kingdom

Conditions studied

Asthma Acute — all drugs for Asthma Acute →

Sponsor

University of East Anglia

Who can join

18 and older, any sex, with Asthma Acute. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to assess the feasibility of capturing data on exhaled breath compounds during an acute asthma exacerbation. In addition to assessing the feasibility of such a study the investigators will collect data on exploratory outcomes including the ability of breath biomarkers to distinguish between controlled and exacerbated states and their ability to differentiate between triggers of exacerbation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Asthma Acute

Currently open trials in the same condition.

NCT07412769 — ASMact: Study on Management of Bronchial Asthma · recruiting
NCT07431021 — Children's Health, Respiratory Inflammation and Short-term Air Pollution · NA · recruiting
NCT07055542 — Creating A Risk Assessment Tool for Thunderstorm Asthma: the CARISTA Study · NA · recruiting
NCT06377345 — Remote Patient Monitoring Solution for Chronic Respiratory Disease Management · NA · recruiting

Other University of East Anglia trials

Trials by the same sponsor.

NCT07512388 — Acceptance and Commitment Therapy for Post-Stroke Adjustment Via Telerehabilitation · NA · active not recruiting
NCT06733103 — Pilot of Cognitive Stimulation Therapy for Pre-frail Stroke Survivors · NA · completed
NCT06971718 — Coronary Bifurcations With Ischaemia and Flow Assessment · recruiting
NCT05928104 — Optimising Pharmacist-led Medication Reviews in Primary Care · completed
NCT06451965 — SCED - Wisdom Enhancement for Post-Stroke Depression · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03084016 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of East Anglia
Last refreshed: 20 October 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03084016.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing